Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Ritu Aneja (4 out of 10 patents)

Padmashree C G Rida (3 out of 3 patents)

Venkata Subba Rao Mukkavilli (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 10242153 - Method for determining the risk profile of neoplastic tissue (2019-03-26),

2. 10213448 - Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof (2019-02-26),

3. 9857354 - Compositions and methods for prognosis and treatment of neoplasm (2018-01-02),

4. 9589100 - Method for determining the risk profile of neoplastic tissue (2017-03-07),

Novazoi Theranostics is a leading biotechnology company specializing in the development of innovative diagnostic tools and personalized treatment solutions for various diseases. Our cutting-edge technologies and expertise in molecular biology enable us to provide accurate and timely diagnosis, leading to more effective and targeted therapies for patients. With a strong commitment to advancing precision medicine, Novazoi Theranostics is dedicated to improving patient outcomes and transforming the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#4 in Rancho Palos Verdes, CA

#13,660 in California

#58,988 in US

Rancho Palos Verdes, CA, United States of America

Novazoi Theranostics

Forward Citations = 1

3 inventors:

Ritu Aneja (4 out of 10 patents)

Padmashree C G Rida (3 out of 3 patents)

Venkata Subba Rao Mukkavilli (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com